In contrast to the current findings, a study investigating the association between Trx expression and survival in patients with ovarian cancer found that high nuclear/low cytoplasmic Trx expression was associated with significantly better overall and progression-free survival compared with the other three groups, regardless of whether they were evaluated separately or in combination [25]. Here, TXN is linked to ovarian carcinoma.